Mesenchymal stem cells - Sources and clinical applications

被引:106
作者
Klingemann, Hans [2 ]
Matzilevich, David [3 ]
Marchand, James [1 ]
机构
[1] Tufts Med Ctr, Dept Anat, Boston, MA 02111 USA
[2] Res Inst, Div Hematol Oncol & Mol Oncol, Boston, MA USA
[3] New England Cord Blood Bank, Newton, MA USA
关键词
mesenchymal stem cells; MSC; differentiation; plasticity;
D O I
10.1159/000142333
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although mesenchymal stem cells (MSC) from different tissue sources share many characteristics and generally fulfill accepted criteria for MSC (plastic adherence, certain surface marker expression, and ability to differentiate into mesenchymal tissues), we are increasingly learning that they can be distinguished at the level of cytokine production and gene expression profiles. Their ability to differentiate into different tissues including endodermal and ectodermal lineages, also varies according to tissue origin. Importantly, MSC from fetal sources can undergo more cell divisions before they reach senescence than MSC from adult tissue such as bone marrow or adipose tissue. As we learn more about the differentiation and plasticity of MSC from different sources, health care providers in the future will use them tailored to different medical indications.
引用
收藏
页码:272 / 277
页数:6
相关论文
共 50 条
  • [41] Applications of Mesenchymal Stem Cells in Liver Fibrosis: Novel Strategies, Mechanisms, and Clinical Practice
    Zhu, Mengmei
    Hua, Tianzhen
    Ouyang, Tao
    Qian, Huofu
    Yu, Bing
    STEM CELLS INTERNATIONAL, 2021, 2021
  • [42] Immunomodulatory properties of mesenchymal stem cells/dental stem cells and their therapeutic applications
    Peishan Li
    Qianmin Ou
    Songtao Shi
    Changshun Shao
    Cellular & Molecular Immunology, 2023, 20 : 558 - 569
  • [43] HUMAN WHARTON'S JELLY MESENCHYMAL STEM CELLS: PROPERTIES, ISOLATION AND CLINICAL APPLICATIONS
    Borys-Wojcik, S.
    Brazert, M.
    Jankowski, M.
    Ozegowska, K.
    Chermula, B.
    Piotrowska-Kempisty, H.
    Bukowska, D.
    Antosik, P.
    Pawelczyk, L.
    Nowicki, M.
    Jeseta, M.
    Kempisty, B.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (01) : 119 - 123
  • [44] Production of mesenchymal stem cells in clinical use
    Bourin, Philippe
    Sensebe, Luc
    HEMATOLOGIE, 2005, 11 (06): : 373 - 383
  • [45] Immunomodulation by mesenchymal stem cells and clinical experience
    Le Blanc, K.
    Ringden, O.
    JOURNAL OF INTERNAL MEDICINE, 2007, 262 (05) : 509 - 525
  • [46] Concise Review: Mesenchymal Stem Cells for Diabetes
    Dominguez-Bendala, Juan
    Lanzoni, Giacomo
    Inverardi, Luca
    Ricordi, Camillo
    STEM CELLS TRANSLATIONAL MEDICINE, 2012, 1 (01) : 59 - 63
  • [47] Clinical Trials With Mesenchymal Stem Cells: An Update
    Squillaro, Tiziana
    Peluso, Gianfranco
    Galderisi, Umberto
    CELL TRANSPLANTATION, 2016, 25 (05) : 829 - 848
  • [48] The effect of different sources of mesenchymal stem cells on microglia states
    Xin, Qiang
    Zhu, Wenhao
    He, Chuan
    Liu, Tianyi
    Wang, Haifeng
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [49] Eminent Sources of Adult Mesenchymal Stem Cells and Their Therapeutic Imminence
    Macrin, Dannie
    Joseph, Joel P.
    Pillai, Aruthra Arumugam
    Devi, Arikketh
    STEM CELL REVIEWS AND REPORTS, 2017, 13 (06) : 741 - 756
  • [50] Challenges of mesenchymal stem cells in the clinical treatment of COVID-19
    Li, Luping
    Zhang, Xiaoshuang
    Wu, Yawen
    Xing, Cencan
    Du, Hongwu
    CELL AND TISSUE RESEARCH, 2024, 396 (03) : 293 - 312